Daniel Judge, MD, discusses data from a prespecified analysis of ATTRibute-CM examining the effects of acoramidis with and without concomitant tafamidis use.
Daniel Judge, MD
Advertisement
Daniel P. Judge, MD, is the Edwin W. and Teresa H. Rogers Endowed Chair for Cardiovascular Research at the Medical University of South Carolina.
Articles by Daniel Judge, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
TRIUMPH-1: Retatrutide Substantially Lowers Weight, BMI in Patients With Obesity or Overweight
2
TRANSCEND-T2D-1: Retatrutide Demonstrates Superior Weight Loss and A1c Results Versus Placebo
3
High-Dose Semaglutide Preserves Kidney Function, Reduces Inflammation in Obesity Without Diabetes
4
Semaglutide 7.2 mg Shows Greater BMI, Cardiometabolic Gains in T2D
5